MD05

DB06375InvestigationalSmall molecule

MD05 is a beta-tricalcium phosphate (beta-TCP) coated with recombinant human growth/differentiation factor-5 (rhGDF-5).

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in periodontal disease.Curator reviewed
Code names
MD-05

Which companies are running trials of MD05, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account